Fenton; Garry
Patent Applications and Registrations
Patent applications and USPTO patent grants for Fenton; Garry.The latest application filed is for "organic compounds".
Company Profile
0.24.25
- Fenton; Garry - Harlow GB
- Fenton; Garry - Dagenham GB
- Fenton; Garry - Essex GB
- Fenton; Garry - Brentwood GB
- Fenton; Garry - West Malling GB
- Fenton; Garry - Kent GB
Patent Activity
| Patent | Date |
|---|---|
| Organic Compounds App 20130012485 - Baschlin; Daniel Kaspar ; et al. | 2013-01-10 |
| Compounds as PDE IV and TNF inhibitors Grant 8,129,537 - Fenton , et al. March 6, 2 | 2012-03-06 |
| EP.sub.2 receptor agonists Grant 8,080,567 - Oxford , et al. December 20, 2 | 2011-12-20 |
| Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators Grant 7,902,224 - Edwards , et al. March 8, 2 | 2011-03-08 |
| Organic compounds Grant 7,888,351 - Baeschlin , et al. February 15, 2 | 2011-02-15 |
| Organic Compounds App 20110034462 - Baeschlin; Daniel Kaspar ; et al. | 2011-02-10 |
| EP.sub.4 receptor antagonists Grant 7,858,644 - Oxford , et al. December 28, 2 | 2010-12-28 |
| EP2 Receptor Agonists App 20100261760 - Oxford; Alexander William ; et al. | 2010-10-14 |
| EP.sub.2 receptor agonists Grant 7,803,841 - Oxford , et al. September 28, 2 | 2010-09-28 |
| Compounds as PDE IV and TNF Inhibitors App 20100240677 - FENTON; Garry ; et al. | 2010-09-23 |
| Ep2 Receptor Agonists App 20100130556 - Oxford; Alexander William ; et al. | 2010-05-27 |
| EP2 receptor agonists Grant 7,662,839 - Oxford , et al. February 16, 2 | 2010-02-16 |
| Compounds as PDE IV and TNF inhibitors Grant 7,652,144 - Fenton , et al. January 26, 2 | 2010-01-26 |
| Ep2 Receptor Agonists App 20090298899 - Oxford; Alexander William ; et al. | 2009-12-03 |
| Organic Compounds App 20090281069 - Baeschlin; Daniel Kaspar ; et al. | 2009-11-12 |
| Furan derivatives as EP.sub.4 receptor antagonists Grant 7,569,602 - Clark , et al. August 4, 2 | 2009-08-04 |
| Compounds App 20090192138 - Baeschlin; Daniel Kaspar ; et al. | 2009-07-30 |
| Ep4 Receptor Antagonists App 20090143437 - Oxford; Alexander W. ; et al. | 2009-06-04 |
| EP.sub.4 receptor antagonists Grant 7,528,157 - Oxford , et al. May 5, 2 | 2009-05-05 |
| EP.sub.4 receptor antagonists Grant 7,507,754 - Oxford , et al. March 24, 2 | 2009-03-24 |
| Ep4 Receptor Antagonists App 20080306117 - Clark; David Edward ; et al. | 2008-12-11 |
| EP.sub.4 receptor antagonists Grant 7,417,068 - Clark , et al. August 26, 2 | 2008-08-26 |
| Compounds as PDE IV and TNF Inhibitors App 20080132706 - FENTON; Garry ; et al. | 2008-06-05 |
| Ep2 Receptor Agonists App 20080119526 - Oxford; Alexander William ; et al. | 2008-05-22 |
| EP4 receptor antagonists App 20080039502 - Oxford; Alexander W. ; et al. | 2008-02-14 |
| EP2 receptor agonists Grant 7,326,732 - Oxford , et al. February 5, 2 | 2008-02-05 |
| Tetrahydro-Naphthalene Derivatives as Glucocorticoid Receptor Modulators App 20070224130 - Edwards; Christine ; et al. | 2007-09-27 |
| Furan derivatives as ep4 receptor antagonists App 20070135503 - Clark; David Edward ; et al. | 2007-06-14 |
| Ep4 Receptor Antagonists App 20070123575 - Oxford; Alexander W. ; et al. | 2007-05-31 |
| Substituted tetrahydroisoquinolines Grant 7,211,586 - Fenton , et al. May 1, 2 | 2007-05-01 |
| EP.sub.4 receptor antagonists Grant 7,196,089 - Oxford , et al. March 27, 2 | 2007-03-27 |
| Substituted alkanoic acids Grant 7,166,616 - Harris , et al. January 23, 2 | 2007-01-23 |
| Compounds as PDE IV and TNF-inhibitors Grant 7,045,660 - Fenton , et al. May 16, 2 | 2006-05-16 |
| Compounds as PDE IV and TNF-inhibitors App 20060084809 - Fenton; Garry ; et al. | 2006-04-20 |
| EP2 receptor agonists App 20050256170 - Oxford, Alexander William ; et al. | 2005-11-17 |
| EP4 receptor antagonists App 20050124676 - Clark, David Edward ; et al. | 2005-06-09 |
| EP4 receptor antagonists App 20040192767 - Oxford, Alexander W. ; et al. | 2004-09-30 |
| Compounds as PDE IV and TNF-inhibitors App 20040171618 - Fenton, Garry ; et al. | 2004-09-02 |
| Indane derivatives Grant 6,762,199 - Fenton , et al. July 13, 2 | 2004-07-13 |
| Substituted tetrahydroisoquinolines App 20040122047 - Fenton, Garry ; et al. | 2004-06-24 |
| Substituted alkanoic acids App 20040006056 - Harris, Neil Victor ; et al. | 2004-01-08 |
| Indane derivatives App 20030199564 - Fenton, Garry ; et al. | 2003-10-23 |
| Compounds as PDE IV and TNF-inhibitors App 20030013713 - Fenton, Garry ; et al. | 2003-01-16 |
| Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group Grant 6,255,326 - Ashton , et al. July 3, 2 | 2001-07-03 |
| Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group Grant 6,096,768 - Ashton , et al. August 1, 2 | 2000-08-01 |
| Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group Grant 5,935,978 - Fenton , et al. August 10, 1 | 1999-08-10 |
| Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- o r Grant 5,840,724 - Fenton , et al. November 24, 1 | 1998-11-24 |
| Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group Grant 5,679,696 - Fenton , et al. October 21, 1 | 1997-10-21 |
| Isoquinolinones Grant 5,004,747 - Ashton , et al. April 2, 1 | 1991-04-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 